This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Osaka University, National Institutes of Biomedical Innovation, Health and Nutrition, The Hospital for Sick Children. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,044 
1 out of 23 
1 out of 167 
Years Active: 2019-2023
Title: Masayuki Nakamori: Innovator in Genetic Medicine
Introduction
Masayuki Nakamori is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of genetic medicine, particularly in the treatment of diseases associated with DNA instability. With a total of three patents to his name, Nakamori's work is paving the way for innovative therapeutic approaches.
Latest Patents
Nakamori's latest patents include groundbreaking methods for treating diseases caused by repeat DNA instability. These methods aim to inhibit the further expansion of repeat DNA and, in some cases, reduce the size of the repeat DNA. Another notable patent involves an α-synuclein expression inhibitor, which provides a nucleic acid medicine that effectively inhibits the expression of the α-synuclein gene. This invention includes an oligonucleotide that binds to the α-synuclein gene and has a length of twelve to twenty bases, showcasing Nakamori's expertise in developing targeted genetic therapies.
Career Highlights
Throughout his career, Nakamori has worked with esteemed institutions such as Osaka University and The Hospital for Sick Children. His research has focused on innovative solutions to complex genetic issues, contributing to advancements in medical science.
Collaborations
Nakamori has collaborated with notable colleagues, including Hideki Mochizuki and Christopher E. Pearson. These partnerships have further enriched his research and development efforts in the field of genetic medicine.
Conclusion
Masayuki Nakamori's contributions to genetic medicine through his innovative patents and collaborations highlight his role as a leading inventor in this critical area of research. His work continues to inspire advancements in the treatment of genetic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile